Rebecca Epperly
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rebecca Epperly as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:15 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07222735 · Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory SarcomasSt. Jude Children's Research Hospital · recruiting · Sarcoma, Childhood Osteosarcoma, Childhood Rhabdomyosarcoma · principal investigator
- Ph1NCT06777979 · CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital · recruiting · Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia · principal investigator
- N/ANCT06579469 · Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell TherapySt. Jude Children's Research Hospital · recruiting · B-ALL, Hematologic Malignancy, Solid Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Hypofractionated radiation in combination with B7-H3-CAR T cells for pediatric patients with relapsed/refractory sarcomasK08CA300913 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2025 to 2026 · $289,893 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in ewing sarcoma.